Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Additional file 1: of The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Huang Ju Tu
(Contributor)
Yi-Jyun Lin
(Contributor)
Min Wu Chao
(Contributor)
Ting Yi Sung
(Contributor)
Yi Wen Wu
(Contributor)
Yi Ying Chen
(Contributor)
Mei-Hsiang Lin
(Contributor)
Jing-Ping Liou
(Contributor)
Shiow-Lin Pan
(Contributor)
Chia Ron Yang
(Contributor)
Taipei Medical University
Department of Pharmaceutical Sciences
Ph.D. Program in Drug Discovery and Development Industry
TMU Research Center of Drug Discivery
TMU Research Center of Thoracic Medicine
TMU Research Center of Cancer Translational Medicine
Ph.D. Program for Cancer Molecular Biology and Drug Discovery
Master Program in Graduate Institute of Cancer Biology and Drug Discovery
Master Program in Clinical Genomics and Proteomics
Dataset
Overview
Research output
(1)
Research output
Research output per year
2018
2018
2018
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2018
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Tu, H. J.
,
Lin, Y. J.
,
Chao, M. W.
,
Sung, T. Y.
,
Wu, Y. W.
,
Chen, Y. Y.
,
Lin, M. H.
,
Liou, J. P.
,
Pan, S. L.
&
Yang, C. R.
,
Dec 29 2018
,
In:
Clinical Epigenetics.
10
,
1
, 162.
Research output
:
Contribution to journal
›
Article
›
peer-review
Leukemia
100%
Vincristine
75%
Histone Deacetylase 6
56%
Doxorubicin
48%
Drug Therapy
30%
19
Citations (Scopus)